[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356524-105":59,"doc-detail-356524-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","silencing-rpl9-promotes-malignant-proliferation-in-breast-cancer-cells","Silencing RPL9 promotes malignant proliferation in breast cancer cells","","Objective: identify RNA-binding proteins (RBPs) linked to breast cancer (BRCA) prognosis and build an RBP-based prognostic scoring model and clinical nomogram, while examining the functional role of RPL9 in BRCA cell proliferation and apoptosis. Methods: TCGA-derived RNA-sequencing and clinical data were used with differential expression, Cox, and LASSO regression to define prognosis-related RBPs and a risk model, then clinical integration, TMB/TIME/immune checkpoint comparisons, and CCK-8 plus flow cytometry apoptosis assays. Results: nine RBPs formed a model predicting 3-, 5-, and 9-year survival with external robustness. High-risk patients showed higher TMB, lower immune scores, reduced CD8+ infiltration, and decreased checkpoint expression. Conclusion: RPL9 downregulation related to poorer outcomes, driving proliferation and increasing apoptosis inhibition, supporting therapeutic targeting.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/silencing-rpl9-promotes-malignant-proliferation-in-breast-cancer-cells/356524/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/silencing-rpl9-promotes-malignant-proliferation-in-breast-cancer-cells/356524.png","ImageObject",300,407,{"name":92,"@type":93},"Mia  ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main objective regarding breast cancer prognosis?","Question",{"text":112,"@type":113},"To identify prognosis-associated RNA-binding proteins (RBPs) for BRCA and construct an RBP-based prognostic scoring model plus a clinical nomogram.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the study evaluate the functional role of RPL9 in BRCA cells?",{"text":117,"@type":113},"It uses functional assays including CCK-8 proliferation and flow cytometry-based apoptosis analyses in BRCA cell lines to assess effects of RPL9.",{"name":119,"@type":110,"acceptedAnswer":120},"What immune microenvironment differences are observed between high- and risk groups?",{"text":121,"@type":113},"High-risk patients show higher tumor mutational burden, lower immune scores, reduced CD8+ T-cell infiltration, and decreased immune checkpoint expression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356524,1790179911,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Silencing RPL9 promotes malignant proliferation in breast cancer cells  \nTong Zhu 1*, Junze Dai2,3*, Wenxin Li3*, Huiyu Zhang2, Yuxuan Song4, Dingye Zhang4, Ruibin Liu4, Xin Wang4, Zhaohu Shi4, Hailin Tang5, Xudong Zhu3,4,6 and Yefu Liu3,6  \nInternational Journal of Immunopathology and Pharmacology Volume 40: 1–26  \n© The Author(s) 2026  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/03946320261422055](DOI: 10.1177/03946320261422055)[ ](DOI: 10.1177/03946320261422055)[journals.sagepub.com/home/iji](journals.sagepub.com/home/iji)  \nAbstract  \nObjective: To identify key RNA-binding proteins (RBPs) associated with breast cancer (BRCA) prognosis and to construct an RBP-based prognostic scoring model and clinical nomogram. Additionally, to explore the functional role of RPL9 in BRCA cell proliferation and apoptosis.  \nIntroduction: Breast cancer is a molecularly heterogeneous malignancy in which posttranscriptional dysregulation contributes significantly to tumor progression. RNAbinding proteins regulate multiple steps of RNA metabolism and have emerged as promising prognostic biomarkers and therapeutic targets in BRCA.  \nMethods: RNA-sequencing data and clinical information of BRCA patients were obtained from TCGA. Differential expressions, Cox, and LASSO regression analyses were performed to identify prognosis-related RBPs and establish a risk scoring model. A clinical nomogram integrating the model with clinicopathological features was generated. Tumor mutational burden (TMB), tumor immune microenvironment (TIME), and immune checkpoint expression were analyzed between risk groups. Functional assays, including CCK-8 proliferation and flow cytometry–based apoptosis analyses, were conducted in BRCA cell lines to determine the role of RPL9.  \nResults: Nine prognosis-related RBPs were identified and used to construct the RBPbased prognostic scoring model, which effectively predicted 3-, 5-, and 9-year survival outcomes. The model remained robust in an external validation cohort. A clinical nomogram based on the model showed strong predictive performance. High-risk patients displayed higher TMB, lower immune scores, reduced CD8⁺ T-cell infiltration, and decreased immune checkpoint expression.  \n1 Department of Breast Surgery, Panjin Central Hospital, Panjin, Liaoning, China 2Graduate School, Dalian Medical University, Dalian, Liaoning, China  \n3Department of Hepatopancreatobiliary Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China  \n4Department of General Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China  \n5State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China  \n6Liaoning Provincial Key Laboratory of Precision Medicine for Malignant Tumors, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China *These authors contributed equally to this work.  \nCorresponding authors:  \nHailin Tang, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China.  \nEmail: [tanghl@sysucc.org.cn](tanghl@sysucc.org.cn)  \nXudong Zhu, Department of General Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Xiaoheyan Road 44, Shenyang, Liaoning 110042, China.  \n[Email: xdzhu@cmu.edu.cn](Email: xdzhu@cmu.edu.cn)  \nYefu Liu, Department of Hepatopancreatobiliary Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China.  \nEmail: [97902153@cmu.edu.cn](97902153@cmu.edu.cn)  \nCreative Commons Non C","cbCaivOldSUHOAkI","https://ap.wps.com/l/cbCaivOldSUHOAkI","pdf",10965734,26,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What is the study’s main objective regarding breast cancer prognosis?\",\"answer\":\"To identify prognosis-associated RNA-binding proteins (RBPs) for BRCA and construct an RBP-based prognostic scoring model plus a clinical nomogram.\"},{\"question\":\"How does the study evaluate the functional role of RPL9 in BRCA cells?\",\"answer\":\"It uses functional assays including CCK-8 proliferation and flow cytometry-based apoptosis analyses in BRCA cell lines to assess effects of RPL9.\"},{\"question\":\"What immune microenvironment differences are observed between high- and risk groups?\",\"answer\":\"High-risk patients show higher tumor mutational burden, lower immune scores, reduced CD8+ T-cell infiltration, and decreased immune checkpoint expression.\"}]","Silencing RPL9 promotes malignant proliferation in breast cancer cells | PDF",1790125811,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f25bcb28877b9c1af6cf8a50de54d54d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec29773c31c497ee300c07e277f67f70.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b4db24f5fb8b354813c05906dcfb3e4.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17629f33670f93a069a1b5f9bdc2f9c3.webp",980,1306]